BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in BioLineRx Ltd. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −20 vs. Q4 2024
- Shares held
- 9.46K
- −40.7K (−81.1%) vs. Q4 2024Converted for a 1-for-40 split
- Total value
- $28.0K
- −$407.9K (−93.6%) vs. Q4 2024
- New holders
- 4
- 4 more added
- Sold out
- 24
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 3,000 | $8.88K | 0.00% | +2,862+2,068.0% | AddedConverted for a 1-for-40 split |
| Morgan Stanley | 2,244 | $6.64K | 0.00% | +266+13.5% | AddedConverted for a 1-for-40 split |
| BNP Paribas Arbitrage, SA | 1,748 | $5.17K | 0.00% | +315+21.9% | AddedConverted for a 1-for-40 split |
| Rhumbline Advisers | 1,530 | $4.52K | 0.00% | +456+42.5% | AddedConverted for a 1-for-40 split |
| JPMorgan Chase & Co | 375 | $1.11K | 0.00% | +375 | New |
| Nemes Rush Group LLC | 300 | $888 | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| GWM Advisors LLC | 107 | $317 | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| Group One Trading, L.P. | 79 | $234 | 0.00% | +79 | New |
| UBS Group AG | 71 | $210 | 0.00% | −159−69.1% | ReducedConverted for a 1-for-40 split |
| SBI Securities Co., Ltd. | 2 | $6 | 0.00% | −76−97.4% | ReducedConverted for a 1-for-40 split |
| Bank of America Corp | 2 | $6 | 0.00% | +2 | New |
| Danske Bank A/S | 2 | $6 | 0.00% | +2 | New |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −25,250−100.0% | Sold outConverted for a 1-for-40 split |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −4,161−100.0% | Sold outConverted for a 1-for-40 split |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −2,353−100.0% | Sold outConverted for a 1-for-40 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold outConverted for a 1-for-40 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,180−100.0% | Sold outConverted for a 1-for-40 split |
| Orin Green Financial, LLC | 0 | $0 | 0.00% | – | Sold outConverted for a 1-for-40 split |
| Gradient Investments LLC | 0 | $0 | 0.00% | −1,035−100.0% | Sold outConverted for a 1-for-40 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-40 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −883−100.0% | Sold outConverted for a 1-for-40 split |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −792−100.0% | Sold outConverted for a 1-for-40 split |
| Citigroup Inc | 0 | $0 | 0.00% | −783−100.0% | Sold outConverted for a 1-for-40 split |
| Watts Gwilliam & Co., LLC | 0 | $0 | 0.00% | −850−100.0% | Sold outConverted for a 1-for-40 split |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −502−100.0% | Sold outConverted for a 1-for-40 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −505−100.0% | Sold outConverted for a 1-for-40 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −383−100.0% | Sold outConverted for a 1-for-40 split |
| Creative Planning | 0 | $0 | 0.00% | −325−100.0% | Sold outConverted for a 1-for-40 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −298−100.0% | Sold outConverted for a 1-for-40 split |
| Weaver Consulting Group | 0 | $0 | 0.00% | −275−100.0% | Sold outConverted for a 1-for-40 split |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −263−100.0% | Sold outConverted for a 1-for-40 split |
| Hibernia Wealth Partners, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold outConverted for a 1-for-40 split |
| Neville Rodie & Shaw Inc | 0 | $0 | 0.00% | −250−100.0% | Sold outConverted for a 1-for-40 split |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −120−100.0% | Sold outConverted for a 1-for-40 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold outConverted for a 1-for-40 split |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-40 split |